Dividend Details

CORONA REMEDIES LTD.

NSE : CORONABSE : 544644ISIN CODE : INE02ZQ01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE1579.60-2.6 (-0.16 %)
PREV CLOSE ( ) 1582.20
OPEN PRICE ( ) 1571.85
BID PRICE (QTY) 1574.00 (7)
OFFER PRICE (QTY) 1579.70 (12)
VOLUME 1475
TODAY'S LOW / HIGH ( )1542.75 1591.95
52 WK LOW / HIGH ( )1336.95 1658.7
NSE1579.10-2.3 (-0.15 %)
PREV CLOSE( ) 1581.40
OPEN PRICE ( ) 1552.60
BID PRICE (QTY) 1576.50 (1)
OFFER PRICE (QTY) 1579.20 (1)
VOLUME 5935
TODAY'S LOW / HIGH( ) 1545.00 1589.40
52 WK LOW / HIGH ( )1336.6 1660.8

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.